Delivery Order SPE2DB22D1202-SPE2DB24FUSJ1
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of the for-profit company Cencora, Inc., to supply WEGOVY 1 MG/0.5 ML PEN 0.5ML pharmaceutical products. The contract has a ceiling value of $1,894.34 and a period of performance through April 9, 2024. This delivery order was issued under an existing indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4563924188 - WEGOVY 1 MG/0.5 ML PEN 0.5ML. The contract has a total ceiling value of $1,645.62 and a period of performance through March 12, 2024. Amerisourcebergen Drug Corp is the prime contractor on this award, which does not have any set-aside designation. This delivery order is associated with a larger...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract valued at $1,645.62 to AmerisourceBergen Drug Corp's Corporate Office Division for the supply of WEGOVY 0.5 MG/0.5 ML PEN 0.5ML pharmaceutical products. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, to provide a comprehensive range of pharmaceutical products and medical...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading pharmaceutical distribution company. The contract is for the supply of WEGOVY 0.25 MG/0.5 ML PEN 0.5ML, a specialty pharmaceutical product, with a potential value of $1,344.53 and a completion date of February 27, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order for $1,097.08 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide WEGOVY 1.7 MG/0.75 ML PEN 0.75ML pharmaceutical products. This order is part of an indefinite delivery contract (IDC) with a potential value of up to $999,999,999.00 awarded to Amerisourcebergen Drug Corp as the sole prime contractor to deliver a comprehensive range of pharmaceutical products and medical supplies to...
- The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide WEGOVY 0.5 MG/0.5 ML PEN 0.5ML. The $3,470.17 delivery order has a performance period ending on February 13, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. This award is part of a larger indefinite delivery contract (IDC) between Amerisourcebergen Drug Corp...
- The U.S. Department of Defense, through the Defense Logistics Agency (DLA) Troop Support Medical, awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4564066888 ! WEGOVY 1 MG/0.5 ML PEN 0.5ML. The contract, valued at $26,329.92, has an ultimate completion date of March 19, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this award. This delivery...
- The Defense Logistics Agency (DLA) has awarded a delivery order contract to Amerisourcebergen Drug Corp for the supply of WEGOVY 0.25 MG/0.5 ML PEN 0.5ML pharmaceutical products. The contract, valued at $22,044.67, has a firm fixed price and an ultimate completion date of September 17, 2024. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is the prime contractor for this contract, which is not designated as a set-aside. This delivery order contract is part of a larger Indefinite...
- This federal contract award, valued at $1,097.08, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of WEGOVY 0.25 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, and has an ultimate completion date of March 8, 2024. The contract is a Delivery Order under a Firm Fixed Price arrangement, with no set-aside designation. Amerisourcebergen Drug Corp is a major...
- The U.S. Defense Logistics Agency (DLA) awarded a $41,692.55 firm-fixed-price delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide WEGOVY 0.25 MG/0.5 ML PEN 0.5ML. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical to deliver a wide range of medical commodities and pharmaceuticals in support of military treatment programs and facilities worldwide....
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB24FUSJ1Delivery Order
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., to provide WEGOVY 0.25 MG/0.5 ML PEN 0.5ML pharmaceuticals. The contract has a total potential value of $1,074.54 and a completion date of March 5, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside was used for this award. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded to Amerisourcebergen Drug Corp by DLA, with a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceuticals and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 3/4/24 |